Go

Breaking News on Contract Research, Manufacturing & Clinical Trials

All feeds

Top Headlines

Charles River rejigs exec roles and preclinical organisation

US CRO Charles River (CRL) has unveiled a raft of executive changes and plans to restructure its PCS unit to provide customers with a more centralised approach to global drug development.

Related news

PDS’ new US office has European focus

UK contracting group Pharmaceutical Development Services (PDS) has set up an office in North Carolina, US to court North America pharma firms for the European development sector.

Medidata inks EDC deal with Roche

Medidata has followed up its successful IPO by inking a deal with Roche, which is reported to be pulling out of PhRMA and the ABPI, to provide the Swiss pharma with an enterprise-wide electronic EDC system.

Teva collaborates to save failed drugs

Teva plans to acquire oncology drugs that fail late-stage clinical trials and collaborate with Optimata to "efficiently rescue" the therapeutics and gain regulatory approval.

Phase Forward signs new deal with GSK

Data management specialist Phase Forward has landed a “multi-million dollar” clinical trial services contract with GSK.

News in brief

Today's headlines across the Pharmaceutical industry

Mylan partners to create FOBs from in-PharmaTechnologist.com

Mylan has followed Teva’s lead by partnering to develop follow-on biologics (FOB), with the Indian generic maker regarding Biocon as the “ideal partner” to help it enter the market.

Spain to build its first vaccine plant from in-PharmaTechnologist.com

The Spanish Ministry of Health is leading a €60m ($84.9m) programme that will build the country’s first vaccine production facility and use Novavax’s recombinant virus-like-particle (VLP) technology.

Pharma: people on the move from in-PharmaTechnologist.com

in-PharmaTechnologist presents its latest round up of appointments in the pharmaceutical sector, including the new president of Sanofi-Aventis France.

Dow to shut 3 US ethylene plants from in-PharmaTechnologist.com

Dow Chemical is closing three US manufacturing plants, including an ethylene production unit in Hahnville, Louisiana in a further bid to expand its specialty chemicals business.

Spotlight

Symyx launches CDMO

Eric Carlson, vice president, life science technology
Matthew Pino, director, business operations - Symyx
All videosAll audio-podcastsAll comments